Literature DB >> 17219960

Trichostatin A regulates hGCN5 expression and cell cycle on Daudi cells in vitro.

Hongli Liu1, Yan Chen, Guohui Cui, Gang Wu, Tao Wang, Jianli Hu.   

Abstract

The expression of human general control of amino acid synthesis protein 5 (hGCN5) in human Burkitt's lymphoma Daudi cells in vitro, effects of Trichostatin A (TSA) on cell proliferation and apoptosis and the molecular mechanism of TSA inhibiting proliferation of Daudi cells were investigated. The effects of TSA on the growth of Daudi cells were studied by 3-(4, 5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT) assay. The effect of TSA on the cell cycle of Daudi cells was assayed by a propidium iodide method. Immunochemistry and Western blot were used to detect the expression of hGCN5. The proliferation of Daudi cells was decreased in TSA-treated group with a 24 h IC50 value of 415.3979 microg/L. TSA induced apoptosis of Daudi cells in a time- and dose-dependent manner. Treatment with TSA (200 and 400 microg/L) for 24 h, the apoptosis rates of Daudi cells were (14.74+/-2.04) % and (17.63+/-1.25) %, respectively. The cell cycle was arrested in G0/G1 phase (50, 100 microg/L) and in G2/M phase (200 microg/L) by treatment with TSA for 24 h. The expression of hGCN5 protein in Daudi cells was increased in 24 h TSA-treated group by immunochemistry and Western blot (P<0.05). It was suggested that TSA as HDACIs could increase the expression of hGCN5 in Daudi cells, and might play an important role in regulating the proliferation and apoptosis of B-NHL cell line Daudi cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17219960     DOI: 10.1007/s11596-006-0512-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  11 in total

1.  FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.

Authors:  Ryohei Furumai; Akihisa Matsuyama; Nobuyuki Kobashi; Kun-Hyung Lee; Makoto Nishiyama; Hidenori Nakajima; Akito Tanaka; Yasuhiko Komatsu; Norikazu Nishino; Minoru Yoshida; Sueharu Horinouchi
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

2.  Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor.

Authors:  E Hu; Z Chen; T Fredrickson; Y Zhu; R Kirkpatrick; G F Zhang; K Johanson; C M Sung; R Liu; J Winkler
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

Review 3.  Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents.

Authors:  T Owa; H Yoshino; K Yoshimatsu; T Nagasu
Journal:  Curr Med Chem       Date:  2001-10       Impact factor: 4.530

4.  Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.

Authors:  John Patrick Alao; Eric W-F Lam; Simak Ali; Laki Buluwela; Walter Bordogna; Peter Lockey; Rana Varshochi; Alexandra V Stavropoulou; R Charles Coombes; David M Vigushin
Journal:  Clin Cancer Res       Date:  2004-12-01       Impact factor: 12.531

5.  Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.

Authors:  J M Mariadason; G A Corner; L H Augenlicht
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

Review 6.  Histone deacetylase as a new target for cancer chemotherapy.

Authors:  M Yoshida; R Furumai; M Nishiyama; Y Komatsu; N Nishino; S Horinouchi
Journal:  Cancer Chemother Pharmacol       Date:  2001-08       Impact factor: 3.333

7.  Functional domains of histone deacetylase-3.

Authors:  Wen-Ming Yang; Shih-Chang Tsai; Yu-Der Wen; Gyorgy Fejer; Edward Seto
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

8.  Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.

Authors:  Kaoru Kahata; Makoto Hayashi; Masahiro Asaka; Ulf Hellman; Hirochika Kitagawa; Jun Yanagisawa; Shigeaki Kato; Takeshi Imamura; Kohei Miyazono
Journal:  Genes Cells       Date:  2004-02       Impact factor: 1.891

9.  Effect and comparison of sodium butyrate and trichostatin A on the proliferation/differentiation of K562.

Authors:  Chunrui Li; Wenli Liu; Fankai Meng; Wei Huang; Jianfeng Zhou; Hanying Sun; Yongdong Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

10.  Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells.

Authors:  M Murata; M Towatari; H Kosugi; M Tanimoto; R Ueda; H Saito; T Naoe
Journal:  Jpn J Cancer Res       Date:  2000-11
View more
  1 in total

Review 1.  Inhibition of histone deacetylases in inflammatory bowel diseases.

Authors:  Rainer Glauben; Britta Siegmund
Journal:  Mol Med       Date:  2011-02-22       Impact factor: 6.354

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.